Inovio Pharmaceuticals Inc (INO) stock is down -20.58% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives INO stock a score of 73 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 85. INO's rank also includes a short-term technical score of 57.
INO has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on INO!
Inovio Pharmaceuticals Inc (INO) stock is lower by -3.09% while the S&P 500 is down -0.08% as of 12:51 PM on Wednesday, Mar 13. INO is down -$0.36 from the previous closing price of $11.51 on volume of 529,323 shares. Over the past year the S&P 500 has gained 31.94% while INO is down -20.58%. INO lost -$6.09 per share in the over the last 12 months.
Click Here to get the full Stock Report for Inovio Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
